Applying phage display techniques, we identified a peptide target for IGF2BP2 which was confirmed to be highly expressed in ESCC cell lines or tumor tissue and may serve as an imaging target for ESCC. This evidence concerns the gene IGF2BP2 and esophageal squamous cell carcinoma.